Cargando…
Mortality and Major Adverse Cardiac Events in Patients With Breast Cancer Receiving Radiotherapy: The First Decade
BACKGROUND: Treatment for breast cancer (BC) frequently involves radiotherapy. Guidelines recommend screening for cardiac adverse events starting 10 years after radiotherapy. The rationale for this interval is unclear. METHODS AND RESULTS: We aimed to study cardiovascular event rates in the first de...
Autores principales: | Jacobs, Johanna E. J., L'Hoyes, Wouter, Lauwens, Lieselotte, Yu, Yu‐Ling, Brusselmans, Marius, Weltens, Caroline, Voigt, Jens‐Uwe, Wildiers, Hans, Neven, Patrick, Herrmann, Joerg, Thijs, Lutgarde, Staessen, Jan A., Janssens, Stefan, Van Aelst, Lucas N. L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10227262/ https://www.ncbi.nlm.nih.gov/pubmed/37026536 http://dx.doi.org/10.1161/JAHA.122.027855 |
Ejemplares similares
-
Urinary Proteomic Profile of Arterial Stiffness Is Associated With Mortality and Cardiovascular Outcomes
por: Wei, Dongmei, et al.
Publicado: (2022) -
Detection of secondary metastatic breast cancer by measurement of plasma CA 15.3
por: De Cock, L., et al.
Publicado: (2021) -
Risk factors for predicting heart failure: a subject-level meta-analysis from the HOMAGE database
por: Efremov, Ljupcho, et al.
Publicado: (2015) -
Urinary peptidomic biomarkers of renal function in heart transplant recipients
por: Huang, Qi-Fang, et al.
Publicado: (2019) -
Randomised Double-Blind Comparison of Placebo and Active Drugs for Effects on Risks Associated with Blood Pressure Variability in the Systolic Hypertension in Europe Trial
por: Hara, Azusa, et al.
Publicado: (2014)